03/16/2026
Meet Jeuveau: The New Glow-Up Tox You’ve Been Waiting For ✨
We are now partnering with to bring Jeuveau for faster, smoother and natural results!
• Big news: Jeuveau® won the 2025 Award! 🏆
Recognized for its fast-acting*, long-lasting** results, Jeuveau is the first frown line treatment created exclusively for aesthetics.
✔ Visible results starting in as little as 2 days*
✔ Lasts up to 4 months**
✔ Highly recommended by patients***
Jeuveau is proud to take home the win!
Visit Jeuveau.com to learn more.
awardwinning
For full Product Information, including Boxed Warning and Medication Guide, see or visit evolusrx.com
Jeuveau® (prabotulinumtoxinA-xvfs) is an FDA-approved prescription injectable treatment used to temporarily improve the look of moderate to severe frown lines between the eyebrows (glabellar lines) in adults.
There are risks with treatment ‒ effects of Jeuveau may spread hours to weeks after injection causing serious symptoms. Alert your doctor right away of difficulty swallowing, speaking, breathing, eye problems or muscle weakness, which can be signs of a life-threatening condition. Other serious risks include allergic reactions, heart or eye problems. The most common side effects are headache, eyelid drooping, upper respiratory infection, and increased white blood cell count.
Ask your doctor about Jeuveau and whether it’s right for you.
*About 50% of patients begin showing improvement after two days. Most patients (~69%) achieve complete results by day 30.
**On average, Jeuveau patients receive three treatments per year.
***Consumer Pulse Survey 2024, Data on file. (N=424). 9 out of 10 people treated with Jeuveau would recommend it to a friend or family member.
Intended for US audiences only.
US-JUV-2500612
